1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Stanger, H.E. Syud, F.A. Espinosa, J.F. Giriat, I. Muir, T. Gellman, S.H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C5 H9 N O2 115.130 D-PROLINE D-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 98 12015 12020 10.1073/pnas.211536998 11593011 Length-dependent stability and strand length limits in antiparallel beta -sheet secondary structure. 2001 10.2210/pdb1jy9/pdb pdb_00001jy9 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2241.559 DP-TT2 1 syn polymer no yes TTTTRYVEV(DPR)GKKILQTTTT TTTTRYVEVPGKKILQTTTT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_conn repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-09-19 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_conn.pdbx_leaving_atom_flag SEQUENCE RESIDUE 12 IN THE PEPTIDE IS ORNITHINE. FOR MODELLING, LYSINE WAS USED IN PLACE OF ORNITHINE FOR EASE OF CALCULATION. RCSB Y RCSB 2001-09-11 REL REL The peptide was synthesized by solid phase peptide synthesis. sample ROESY to check for spin diffusion. 1 2D NOESY 3.8 ambient 277 K NOE intensities were qualitatively assigned to be strong, medium, weak or very weak, and assigned constraints of 3, 4, 5, and 6 respectively; a total of 32 restraints were used for DP-TT2. Restraints were checked using "distance check" function within DYANA which showed there were no "lonely" or possibly misassigned NOEs which could unduly influence the final conformation. DYANA was used to generate 500 random structures, which were subsequently annealed. The best 10 structures (fewest restraint violations) were selected. This entry contains the minimized average structure. 1 mM peptide 9:1 H2O:D2O, 100 mM Acetic Acid Guntert, Mumenthaler, Wuthrich structure solution DIANA 1.5 Guntert, Mumenthaler, Wuthrich refinement DIANA 1.5 600 Varian INOVA THR 1 n 1 THR 1 A THR 2 n 2 THR 2 A THR 3 n 3 THR 3 A THR 4 n 4 THR 4 A ARG 5 n 5 ARG 5 A TYR 6 n 6 TYR 6 A VAL 7 n 7 VAL 7 A GLU 8 n 8 GLU 8 A VAL 9 n 9 VAL 9 A PRO 10 n 10 DPR 10 A GLY 11 n 11 GLY 11 A LYS 12 n 12 LYS 12 A LYS 13 n 13 LYS 13 A ILE 14 n 14 ILE 14 A LEU 15 n 15 LEU 15 A GLN 16 n 16 GLN 16 A THR 17 n 17 THR 17 A THR 18 n 18 THR 18 A THR 19 n 19 THR 19 A THR 20 n 20 THR 20 A author_defined_assembly 1 monomeric A DPR 10 D-PROLINE A DPR 10 PRO 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 7 A N VAL 7 A O ILE 14 A O ILE 14 1 A THR 2 -174.13 -43.06 1 A LYS 12 -160.13 -91.40 1 A LYS 13 179.80 -177.41 1 A ILE 14 -176.36 147.94 1 A THR 17 -153.93 37.29 MINIMIZED AVERAGE STRUCTURE OF DP-TT2 1 N N covale 1.360 both A VAL 9 A C VAL 9 1_555 A DPR 10 A N DPR 10 1_555 covale 1.324 both A DPR 10 A C DPR 10 1_555 A GLY 11 A N GLY 11 1_555 DE NOVO PROTEIN beta-hairpin, DE NOVO PROTEIN 1JY9 PDB 1 1JY9 1 20 1JY9 1 20 1JY9 A 1 1 20 2 anti-parallel A TYR 6 A TYR 6 A VAL 7 A VAL 7 A ILE 14 A ILE 14 A LEU 15 A LEU 15